Virginia M. Klimek

Statistics

Publications

Citations

10.8K

H-Index

Active since

2000

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Moffitt Cancer Center

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Virginia M. Klimek is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, myelodysplastic syndromes, and molecular oncology.

Publications per year

2000–2024

Publications

Decitabine improves patient outcomes in myelodysplastic syndromes

Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations

Medicine, Hematology, Pharmacology +14

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

Ly Vu, Brian F. Pickering, Yuanming Cheng et al. · Nature Medicine · 2017 · 1.3K citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text

Medicine, Genetics, Hematology +16

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Kelly L. Bolton, Ryan Ptashkin, Teng Gao et al. · Nature Genetics · 2020 · 741 citations · Full text

Medicine, Cancer Biology, Oncology +16

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

Richard M. Stone, Daniel J. DeAngelo, Virginia M. Klimek et al. · Blood · 2004 · 660 citations · Full text

Medicine, Molecular Genetics, Oncology +14

1–5 of 61